Larvol Delta - Study-of-CB103-in-Adult-Patients-With-Advanced-or-Metastatic-Solid-Tumours-and-Haematological-Malignancies

CB-103 - Cellestia Biotech

http://clinicaltrials.gov/ct2/show/NCT03422679

Jan 21, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next